Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

GammaCan

GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at preventing metastasis (the spread of cancer to other parts of the body) of a variety of cancers. GammaCan’s first product was entered to phase-II clinical trials.GammaCan’s innovative treatment is based on intravenous Immunoglobulin (IVIg), a safe, non-toxic human plasma-based product currently used and approved for treating a number of immune deficiencies and autoimmune diseases. GammaCan focuses on treating patients in the five years following initial therapy, with the aim of preventing recurrence of disease caused by micrometastasis (single cells left in the body following surgery and chemotherapy). Publications in medical literature by GammaCan scientists and researchers state that IVIg appears to profoundly impact cancer progression in patients being treated with IVIg for immune and autoimmune diseases while concurrently suffering from cancer.GammaCan is constantly looking for new clinical-stage candidates. We have developed the necessary mechanisms and capabilities to efficiently identify, evaluate and execute in-licensing deals. Recognizing that many smaller start-up companies in Israel and Europe lack the financial resources to complete clinical trials, we offer these enterprises a development track for their molecules, thus allowing them to focus on continued development of their platforms and technologies.


Contact Details:
440 Ninth Avenue 17th Floor, Suite 1720
New York
New York
10001
United States of America
Tel:1 212 404 1911
Fax:1 212 404 1450
Email:CDemonte@aol.com
WWW:

www.gammacan.com/




Loading...

GammaCan Clinical Trials:

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 291 times since April 2007, the link to the organisation's website has been followed 58 times

Recent Search Terms used to find this page: GAMMACAN 2009 | gammacan | .

Search for more companies in New York

Search for more companies in New York



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for GammaCan

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.